David Bach is a Cardiology physician affiliated with Michigan Medicine. OpenAlex indexes 240 publications with 7,390 citations (h-index 42); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
325 Briarwood Circle
Building 5
Ann Arbor, MI 481081605
Telephone
734-647-9000Registry record last updated 21 Oct 2019.
Clinical trials
- Hemodynamic Comparison of Tissue Aortic Valves
Sponsor: University of Michigan
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Edwards Lifesciences CorporationProgram year20254 payments$22,706openpaymentsdata.cms.gov ↗
- Edwards Lifesciences CorporationProgram year20246 payments$47,858openpaymentsdata.cms.gov ↗
- Medtronic, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
93.2%Statin30%Atorvastatin Calcium74%Rosuvastatin Calcium26%Part D<11 patientsBeta blocker18.9%Metoprolol Succinate100%Part D≥21 patients+ 4 more classes in this area
Blood & clotting
6.8%Factor Xa inhibitor6.8%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Randomized comparison of exercise haemodynamics of Freestyle, Magna Ease and Trifecta bioprostheses after aortic valve replacement for severe aortic stenosis
European Journal of Cardio-Thoracic Surgery
2016 - Regression of Paravalvular Aortic Regurgitation and Remodeling of Self-Expanding Transcatheter Aortic Valve
JACC. Cardiovascular imaging
2015 - Long-Term Clinical Outcomes 15 Years After Aortic Valve Replacement With the Freestyle Stentless Aortic Bioprosthesis
The Annals of Thoracic Surgery
2013
Similar KOLs
Other experts from the same institution or the same specialty.
Joseph Kolars, MD
Michigan Medicine
Shan Baker, MD
Michigan Medicine
Norman Hogikyan, MD
Michigan Medicine
Wassim Labaki, MD
Michigan Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”